Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 359

1.

Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description.

Cheng A, Dalal D, Butcher B, Norgard S, Zhang Y, Dickfeld T, Eldadah ZA, Ellenbogen KA, Guallar E, Tomaselli GF.

J Am Heart Assoc. 2013 Feb 22;2(1):e000083. doi: 10.1161/JAHA.112.000083.

PMID:
23525420
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).

Cheng A, Zhang Y, Blasco-Colmenares E, Dalal D, Butcher B, Norgard S, Eldadah Z, Ellenbogen KA, Dickfeld T, Spragg DD, Marine JE, Guallar E, Tomaselli GF.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1084-91. doi: 10.1161/CIRCEP.113.001705. Epub 2014 Oct 1.

PMID:
25273351
[PubMed - indexed for MEDLINE]
3.

Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.

Fröhlich GM, Holzmeister J, Hübler M, Hübler S, Wolfrum M, Enseleit F, Seifert B, Hürlimann D, Lehmkuhl HB, Noll G, Steffel J, Falk V, Lüscher TF, Hetzer R, Ruschitzka F.

Heart. 2013 Aug;99(16):1158-65. doi: 10.1136/heartjnl-2013-304185. Epub 2013 Jun 27.

PMID:
23813845
[PubMed - indexed for MEDLINE]
4.

Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.

Wu KC, Gerstenblith G, Guallar E, Marine JE, Dalal D, Cheng A, Marbán E, Lima JA, Tomaselli GF, Weiss RG.

Circ Cardiovasc Imaging. 2012 Mar;5(2):178-86. doi: 10.1161/CIRCIMAGING.111.968024. Epub 2012 Jan 20.

PMID:
22267750
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice.

Masoudi FA, Go AS, Magid DJ, Cassidy-Bushrow AE, Doris JM, Fiocchi F, Garcia-Montilla R, Glenn KA, Goldberg RJ, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Jackson N, Kadish A, Lauer M, Miller AW, Multerer D, Peterson PN, Reifler LM, Reynolds K, Saczynski JS, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Greenlee RT.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):e78-85. doi: 10.1161/CIRCOUTCOMES.112.965368.

PMID:
23170006
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.

Cantero-Pérez EM, Sobrino-Márquez JM, Grande-Trillo A, Lage-Gallé E, Rangel-Sousa D, Esteve-Ruiz IM, Martínez-Martínez A.

Transplant Proc. 2013;45(10):3659-61. doi: 10.1016/j.transproceed.2013.10.017.

PMID:
24314988
[PubMed - indexed for MEDLINE]
7.

Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.

Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, Chow T.

Circ Cardiovasc Qual Outcomes. 2009 Jan;2(1):16-24. doi: 10.1161/CIRCOUTCOMES.108.807123. Epub 2009 Jan 6.

PMID:
20031808
[PubMed - indexed for MEDLINE]
Free Article
8.

Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.

Forleo GB, Della Rocca DG, Papavasileiou LP, Panattoni G, Sergi D, Duro L, Mahfouz K, Magliano G, Santini L, Romeo F.

J Cardiovasc Med (Hagerstown). 2011 Nov;12(11):779-84. doi: 10.2459/JCM.0b013e32834ae458.

PMID:
21941203
[PubMed - indexed for MEDLINE]
9.

Deactivation of implantable cardioverter-defibrillators: results of patient surveys.

Herman D, Stros P, Curila K, Kebza V, Osmancik P.

Europace. 2013 Jul;15(7):963-9. doi: 10.1093/europace/eus432. Epub 2013 Feb 27.

PMID:
23447573
[PubMed - indexed for MEDLINE]
Free Article
10.

Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patients.

Bhavnani SP, Coleman CI, Guertin D, Yarlagadda RK, Clyne CA, Kluger J.

Ann Noninvasive Electrocardiol. 2013 Jul;18(4):379-88. doi: 10.1111/anec.12045. Epub 2013 May 3.

PMID:
23879278
[PubMed - indexed for MEDLINE]
11.

Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.

Parkash R, Sapp JL, Basta M, Doucette S, Thompson K, Gardner M, Gray C, Brownell B, Kidwai H, Cox J.

Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):706-13. doi: 10.1161/CIRCEP.112.970798. Epub 2012 Jun 8.

PMID:
22685111
[PubMed - indexed for MEDLINE]
Free Article
12.

Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA 3rd, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS.

J Am Coll Cardiol. 2013 Apr 9;61(14):1527-35. doi: 10.1016/j.jacc.2013.01.037.

PMID:
23500286
[PubMed - indexed for MEDLINE]
Free Article
13.

Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.

Boriani G, Botto G, Lunati M, Proclemer A, Schmidt B, Erdogan A, Rauhe W, Biffi M, Santi E, Becker D, Messier M, Santini M.

BMC Cardiovasc Disord. 2012 Sep 11;12:72. doi: 10.1186/1471-2261-12-72.

PMID:
22966862
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.

Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, Lee KL, Bardy GH.

Circulation. 2008 Nov 11;118(20):2022-8. doi: 10.1161/CIRCULATIONAHA.107.748962. Epub 2008 Oct 27.

PMID:
18955671
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.

Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP.

Circ Arrhythm Electrophysiol. 2013 Aug;6(4):668-74. doi: 10.1161/CIRCEP.113.000457. Epub 2013 Jul 19. Erratum in: Circ Arrhythm Electrophysiol. 2014 Feb;7(1):185.

PMID:
23873139
[PubMed - indexed for MEDLINE]
Free Article
16.

Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy.

DeWitt ES, Triedman JK, Cecchin F, Mah DY, Abrams DJ, Walsh EP, Gauvreau K, Alexander ME.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1057-63. doi: 10.1161/CIRCEP.114.001569. Epub 2014 Sep 27.

PMID:
25262116
[PubMed - indexed for MEDLINE]
17.

Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.

Barsheshet A, Goldenberg I, Moss AJ, Huang DT, Zareba W, McNitt S, Klein HU, Guetta V.

J Cardiovasc Electrophysiol. 2011 Nov;22(11):1237-42. doi: 10.1111/j.1540-8167.2011.02096.x. Epub 2011 May 26.

PMID:
21615813
[PubMed - indexed for MEDLINE]
18.

Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.

Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV.

Circ Arrhythm Electrophysiol. 2014 Feb;7(1):164-70. doi: 10.1161/CIRCEP.113.001217. Epub 2014 Jan 20. Review.

PMID:
24446023
[PubMed - indexed for MEDLINE]
Free Article
19.

Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.

Ersbøll M, Valeur N, Andersen MJ, Mogensen UM, Vinther M, Svendsen JH, Møller JE, Kisslo J, Velazquez EJ, Hassager C, Søgaard P, Køber L.

JACC Cardiovasc Imaging. 2013 Aug;6(8):851-60. doi: 10.1016/j.jcmg.2013.05.009. Epub 2013 Jul 10.

PMID:
23850252
[PubMed - indexed for MEDLINE]
Free Article
20.

Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.

Kreuz J, Horlbeck F, Schrickel J, Linhart M, Fimmers R, Mellert F, Nickenig G, Schwab JO.

Clin Cardiol. 2012 Sep;35(9):575-9. doi: 10.1002/clc.22018. Epub 2012 Jun 15.

PMID:
22707222
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk